ArticleCell reports. Medicine2024

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

Viviana Rubino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.